# OnCo record paper-firstmappp-sunitinib-metastatic-ppgl-lancet-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-firstmappp-sunitinib-metastatic-ppgl-lancet-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-firstmappp-sunitinib-metastatic-ppgl-lancet-2024" ;
  schema:name "FIRSTMAPPP: sunitinib for metastatic progressive pheochromocytomas and paragangliomas"@en ;
  schema:description "The first randomised trial ever completed in metastatic pheochromocytoma and paraganglioma found that the kinase inhibitor sunitinib roughly doubled the proportion of patients whose disease had not progressed at one year compared with placebo."@en ;
  schema:url <https://onco.cc/key-papers/paper-firstmappp-sunitinib-metastatic-ppgl-lancet-2024/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(23)02554-0>, <https://pubmed.ncbi.nlm.nih.gov/38402886/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(23)02554-0> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Baudin E, Goichot B, Berruti A, et al." ;
  onco:cancers <https://onco.cc/cancers/metastatic-ppgl/> ;
  onco:drugs <https://onco.cc/drugs/sunitinib/> ;
  onco:journals <https://onco.cc/journals/lancet/> .